Blue Jet Healthcare
Ticker > Company >

Blue Jet Healthcare share price

Blue Jet Healthcare Ltd.

NSE: BLUEJET BSE: 544009 SECTOR: Pharmaceuticals & Drugs  35.05 K   34   4

700.20
+1.85 (0.26%)
NSE: Today, 09:34 AM

Price Summary

Today's High

₹ 705

Today's Low

₹ 694.1

52 Week High

₹ 1027.8

52 Week Low

₹ 463.7

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsAverage
The company could improve upon its asset employment.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 12146.05 Cr.

Enterprise Value

₹ 12061.34 Cr.

No. of Shares

17.35 Cr.

P/E

33.87

P/B

9.92

Face Value

₹ 2

Div. Yield

0 %

Book Value (TTM)

₹  70.58

CASH

₹ 84.71 Cr.

DEBT

₹ 0 Cr.

Promoter Holding

86 %

EPS (TTM)

₹  20.67

Sales Growth

-1.3%

ROE

21.45 %

ROCE

28.85%

Profit Growth

2.33 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year-1.3%
3 Year12.56%
5 YearNA

Profit Growth

1 Year2.33%
3 Year4.96%
5 YearNA

ROE%

1 Year21.45%
3 Year30.07%

ROCE %

1 Year28.85%
3 Year39.7%

Debt/Equity

0

Price to Cash Flow

50.34

Interest Cover Ratio

1368.0497

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2025 86.00 0.00
Mar 2025 86.00 0.00
Dec 2024 86.00 0.00
Sep 2024 86.00 0.00
Jun 2024 86.00 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company has been maintaining healthy ROE of 30.0731% over the past 3 years.
  • Company has been maintaining healthy ROCE of 39.7000666666667% over the past 3 years.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 1368.0497.
  • Company has a healthy liquidity position with current ratio of 2.3819.
  • The company has a high promoter holding of 86%.

 Limitations

  • The company has shown a poor profit growth of 4.96001380284827% for the Past 3 years.
  • The company has shown a poor revenue growth of 12.5634181393598% for the Past 3 years.
  • The company has a low EBITDA margin of 0% over the past 5 years.
  • The company is trading at a high PE of 33.87.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
Net Sales 162.9 208.26 318.38 340.45 354.76
Total Expenditure 118.64 138.77 194.37 200.48 233.76
Operating Profit 44.26 69.49 124.01 139.97 120.99
Other Income 8.72 12.07 13.24 12.23 8.25
Interest 0.03 0.02 0.02 0.03 0.69
Depreciation 3.48 4.62 4.75 4.95 5.7
Exceptional Items 0 0 0 0 0
Profit Before Tax 49.47 76.92 132.49 147.21 122.86
Tax 11.69 18.58 33.51 37.12 31.69
Profit After Tax 37.78 58.35 98.98 110.1 91.17
Adjusted EPS (Rs) 2.18 3.36 5.71 6.35 5.26

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 498.93 683.47 720.98 711.6
Total Expenditure 292.08 434.21 501.89 482.37
Operating Profit 206.85 249.26 219.09 229.23
Other Income 8.61 19.41 23.96 28.86
Interest 5.31 3.3 1.36 0.16
Depreciation 19.66 22.15 25.07 28.09
Exceptional Items 0 0 0 -9.74
Profit Before Tax 190.49 243.23 216.61 220.1
Tax 48.87 61.64 56.58 56.34
Net Profit 141.62 181.59 160.03 163.75
Adjusted EPS (Rs.) 8.16 10.47 9.23 9.44

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 9.91 34.69 34.69 34.69
Total Reserves 329.91 486.85 646.79 810.53
Borrowings 28.67 0 0 0
Other N/C liabilities 4.69 17.33 6.7 7.66
Current liabilities 220.05 259.07 318.42 361.59
Total Liabilities 593.22 797.94 1006.61 1214.47
Assets
Net Block 138.92 156.48 151.04 171.94
Capital WIP 2.58 3.43 30.46 147.06
Intangible WIP 0 0 0 0
Investments 0 0 0 15
Loans & Advances 4.66 5.02 15.34 18.98
Other N/C Assets 0.08 0.31 0.17 0.24
Current Assets 446.97 632.7 809.59 861.26
Total Assets 593.22 797.94 1006.61 1214.47
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 190.49 243.23 216.61 220.1
Adjustment 17.03 6.74 17.81 19.08
Changes in Assets & Liabilities -72.71 -75.96 -32.89 13.17
Tax Paid -0.2 -27.59 -59.98 -11.08
Operating Cash Flow 134.61 146.42 141.56 241.26
Investing Cash Flow -56.03 -76.03 -147.25 -263.76
Financing Cash Flow -27.5 -56.15 -4.24 -1.99
Net Cash Flow 51.08 14.25 -9.94 -24.48

Corporate Actions

Investors Details

PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
promoters 86.00 86.00 86.00 86.00 86.00
akshay bansarilal arora 68.99 68.99 68.99 68.99 68.99
archana akshay arora 6.05 6.05 6.05 6.05 6.05
shiven akshay arora 10.96 10.96 10.96 10.96 10.96
PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
investors 14.00 14.00 14.00 14.00 14.00
llp 0.37 0.47 0.43 0.18 0.19
blue daimond properties p... 1.05 1.05 1.05 - -
government pension fund g... 1.89 1.89 - - -

Annual Reports

Title Link
Title Link
 No Annual reports exist for this company.Report us

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
Concall Q3FY24
Concall Q2FY24
TYPE QUARTER Link
TYPE QUARTER Link
Presentation Q4FY25
Presentation Q4FY24
Presentation Q3FY25
Presentation Q3FY24
Presentation Q2FY24

Additional Resources & References

Company News

Blue Jet Healthcare - Quaterly Results 22 Jul, 12:40 PM Blue Jet Healthcare - Quaterly Results 22 Jul, 12:40 PM Blue Jet Healthcare - Quaterly Results 22 Jul, 12:40 PM Blue Jet Healthcare informs about closure of trading window 26 Jun, 5:33 PM Blue Jet Healthcare informs about declaration 16 Jun, 4:54 PM Blue Jet Healthcare informs about outcome of board meeting 16 Jun, 3:58 PM Blue Jet Healthcare informs about earnings call transcript 17 May, 12:45 PM Blue Jet Healthcare informs about newspaper publication 15 May, 5:25 PM Blue Jet Healthcare - Quaterly Results 14 May, 2:10 PM Blue Jet Healthcare - Quaterly Results 14 May, 2:10 PM Blue Jet Healthcare - Quaterly Results 14 May, 2:10 PM Blue Jet Healthcare informs about closure of trading window 27 Mar, 12:34 PM Blue Jet Healthcare informs about analyst meet intimation 18 Mar, 4:41 PM Blue Jet Healthcare informs about earnings call transcript 4 Feb, 5:13 PM Blue Jet Healthcare - Quaterly Results 29 Jan, 1:19 PM Blue Jet Healthcare - Quaterly Results 29 Jan, 1:19 PM Blue Jet Healthcare - Quaterly Results 29 Jan, 1:19 PM Blue Jet Healthcare informs about conference call 27 Jan, 11:11 AM Blue Jet Healthcare submits analyst meet intimation 11 Dec, 4:05 PM Blue Jet Healthcare commissions production block at Ambernath Unit 2 facility 11 Dec, 11:57 AM Blue Jet Healthcare informs about change in directorate 19 Nov, 5:22 PM Blue Jet Healthcare gets consent to start manufacturing at Mahad unit 16 Nov, 1:00 PM Blue Jet Healthcare - Quaterly Results 29 Oct, 1:01 PM Blue Jet Healthcare - Quaterly Results 29 Oct, 1:01 PM Blue Jet Healthcare - Quaterly Results 29 Oct, 1:01 PM Blue Jet Healthcare informs about press release 2 Sep, 4:49 PM Blue Jet Healthcare informs about earnings call transcript 12 Aug, 3:01 PM Blue Jet Healthcare - Quaterly Results 6 Aug, 12:52 PM Blue Jet Healthcare - Quaterly Results 6 Aug, 12:52 PM Blue Jet Healthcare - Quaterly Results 6 Aug, 12:52 PM Blue Jet Healthcare commissions multi- product Production block at Ambernath Unit 2 facility 1 Jul, 2:42 PM Blue Jet Healthcare informs about trading window closure 26 Jun, 5:21 PM Blue Jet Healthcare informs about press release 27 May, 5:05 PM Blue Jet Healthcare informs about investors presentation 27 May, 9:55 AM Blue Jet Healthcare - Quaterly Results 25 May, 9:16 PM Blue Jet Healthcare informs about outcome of board meeting 7 Feb, 1:15 PM Blue Jet Healthcare - Quaterly Results 6 Feb, 2:06 PM Blue Jet Healthcare - Quaterly Results 6 Feb, 2:06 PM Blue Jet Healthcare - Quaterly Results 6 Feb, 2:06 PM Blue Jet Healthcare informs about board meeting 29 Jan, 2:47 PM Blue Jet Healthcare informs about disclosure 4 Jan, 4:17 PM Blue Jet gets nod for PTC for synchronization of 5.615 MW plant capacity 4 Jan, 12:40 PM Blue Jet Healthcare informs about appointment of RTA 20 Nov, 5:26 PM Blue Jet Healthcare informs about transcript of earnings call 18 Nov, 3:43 PM Blue Jet Healthcare coming with IPO to raise upto Rs 840.27 crore 23 Oct, 12:40 PM Blue Jet Healthcare gets SEBI’s approval to float IPO 20 Jan, 11:44 AM Blue Jet Healthcare files DRHP with SEBI for Rs 2,100 crore IPO 6 Sep, 12:18 PM

Blue Jet Healthcare Stock Price Analysis and Quick Research Report. Is Blue Jet Healthcare an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Blue Jet Healthcare. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Blue Jet Healthcare has a PE ratio of 33.7815939049462 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Blue Jet Healthcare has ROA of 14.7451% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Blue Jet Healthcare has a Current ratio of 2.3819.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Blue Jet Healthcare has a ROE of 21.4515%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Blue Jet Healthcare has a Debt to Equity ratio of 0 which means that the company has low proportion of debt in its capital.

  • Sales growth: Blue Jet Healthcare has reported revenue growth of -1.3016% which is poor in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Blue Jet Healthcare for the current financial year is 32.2132721002589%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Blue Jet Healthcare is Rs 1 and the yield is 0%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Blue Jet Healthcare is Rs 20.6725. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Blue Jet Healthcare in Ticker for free. Also, one can get the intrinsic value of Blue Jet Healthcare by using Valuation Calculators, which are available with a Finology ONE subscription. 

Blue Jet Healthcare FAQs

Q1. What is Blue Jet Healthcare share price today?
Ans: The current share price of Blue Jet Healthcare is Rs 698.35.

Q2. What is the market capitalisation of Blue Jet Healthcare?
Ans: Blue Jet Healthcare has a market capitalisation of Rs 12113.957954875 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Blue Jet Healthcare?
Ans: The PE ratio of Blue Jet Healthcare is 33.7815939049462 and the P/B ratio of Blue Jet Healthcare is 9.89475444119822, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Blue Jet Healthcare share?
Ans: The 52-week high share price of Blue Jet Healthcare is Rs 1027.8, and the 52-week low share price of Blue Jet Healthcare is Rs 463.7.

Q5. Does Blue Jet Healthcare pay dividends?
Ans: Currently, Blue Jet Healthcare does not pay dividends. Dividend yield of Blue Jet Healthcare is around 0%.

Q6. What are the face value and book value of Blue Jet Healthcare shares?
Ans: The face value of Blue Jet Healthcare shares is Rs 2, while the book value per share of Blue Jet Healthcare is around Rs 70.5778. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Blue Jet Healthcare?
Ans: Blue Jet Healthcare has a total debt of Rs 0 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Blue Jet Healthcare?
Ans: The ROE of Blue Jet Healthcare is 21.4515% and ROCE of Blue Jet Healthcare is 28.8537%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Blue Jet Healthcare a good buy for the long term?
Ans: The Blue Jet Healthcare long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Blue Jet Healthcare undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Blue Jet Healthcare appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Blue Jet Healthcare’s financials?
Ans: You can review Blue Jet Healthcare’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Blue Jet Healthcare

Blue Jet Healthcare Ltd. Financials: Check Share Price, Balance Sheet, Annual Report, Quarterly Results, Shareholding, Company Profile and News for Company Analysis

Blue Jet Healthcare Ltd. is a leading healthcare company operating in the pharmaceutical industry. Established in [year], the company has a strong presence in the market with a diverse range of products and services. Blue Jet Healthcare specializes in the manufacturing and distribution of high-quality pharmaceutical products, catering to both domestic and international markets.

Blue Jet Healthcare Ltd. - Share Price

Stay updated with the latest share price of Blue Jet Healthcare Ltd. Our website provides real-time information on the company's stock price, allowing investors to make informed decisions. Use our pre-built screening tools to analyze the historical performance of Blue Jet Healthcare stock and identify potential investment opportunities.

Blue Jet Healthcare Ltd. - Balance Sheet

Access the balance sheet of Blue Jet Healthcare Ltd. on our website. Our platform provides downloadable annual reports, allowing investors to analyze the financial health of the company. Utilize our premium features, such as DCF Analysis, BVPS Analysis, Earnings multiple approach, and DuPont analysis, to calculate the fair value of the company's stock.

Blue Jet Healthcare Ltd. - Annual Report

Obtain detailed insights into Blue Jet Healthcare Ltd.'s performance through our downloadable annual reports. These reports provide a comprehensive overview of the company's financial statements, highlights of key achievements, and future growth prospects. Analyze the annual reports to better understand the company's position in the market and evaluate its potential as a long-term investment.

Blue Jet Healthcare Ltd. - Dividend

Learn about the dividend history of Blue Jet Healthcare Ltd. on our website. We provide information on the company's dividend payouts, dividend yield, and dividend growth over the years. Stay informed about the company's dividend policy to gauge its attractiveness as an investment option.

Blue Jet Healthcare Ltd. - Quarterly Result

Stay up to date with the quarterly results of Blue Jet Healthcare Ltd. Our website offers downloadable quarterly reports, allowing investors to analyze the company's financial performance in greater detail. Use our premium features to evaluate key financial ratios and assess the company's profitability, liquidity, and solvency.

Blue Jet Healthcare Ltd. - Stock Price

Track the stock price of Blue Jet Healthcare Ltd. on our website. Our platform provides real-time data, charts, and price trends, enabling investors to make timely investment decisions. Analyze the historical stock price movements to gain insights into market trends and identify potential buying or selling opportunities.

Blue Jet Healthcare Ltd. - Price Chart

Visualize the price movements of Blue Jet Healthcare Ltd.'s stock through our interactive price charts. Our website offers a range of charting tools and indicators, facilitating technical analysis for investors. Analyze trends and patterns to make informed decisions based on historical price data.

Blue Jet Healthcare Ltd. - News

Stay updated with the latest news and updates related to Blue Jet Healthcare Ltd. Our website provides comprehensive coverage of the company's developments, market trends, regulatory changes, and industry updates. Utilize this information to stay informed and make well-informed investment decisions.

Blue Jet Healthcare Ltd. - Concall Transcripts

Access the transcripts of Blue Jet Healthcare Ltd.'s conference calls on our website. These transcripts provide valuable insights into the company's discussions, strategies, and outlook. Stay informed about the company's management's perspectives on various aspects of the business and evaluate their plans for future growth.

Blue Jet Healthcare Ltd. - Investor Presentations

Gain access to Blue Jet Healthcare Ltd.'s investor presentations, offering detailed information on the company's operations, financial performance, and growth plans. These presentations provide investors with an in-depth understanding of Blue Jet Healthcare's business model, competitive advantage, and market prospects. Use these presentations to make informed investment decisions.

Blue Jet Healthcare Ltd. - Promoters

Learn more about the promoters of Blue Jet Healthcare Ltd. Our website provides information on the company's key promoters, their backgrounds, and their contributions to the company's growth. Analyze the promoters' track record and expertise to evaluate their impact on the company's long-term prospects.

Blue Jet Healthcare Ltd. - Shareholders

Stay informed about Blue Jet Healthcare Ltd.'s major shareholders. Our website provides information on the company's significant institutional and retail investors, their shareholdings, and changes in their positions. Analyze the shareholders' confidence in the company to assess its attractiveness as an investment.

Remember, Blue Jet Healthcare Ltd. is a promising healthcare company with significant growth potential in the pharmaceutical industry. Use our website's comprehensive tools and resources to analyze the company's stock and make informed investment decisions. Access the latest information on share prices, balance sheets, annual reports, dividends, quarterly results, and other valuable data to navigate the market successfully and maximize your investment returns. 

Blue Jet Healthcare Balance Sheet Analysis

Blue Jet Healthcare Equity and Liabilities Growth

From March 2021 to March 2024, Blue Jet Healthcare's total liabilities witnessed significant growth from Rs 593.22 Cr to Rs 1,214.47 Cr. This sharp increase can be mainly attributed to the rise in Share Capital from Rs 9.91 Cr in 2021 to Rs 34.69 Cr by March 2024, and a substantial growth in Total Reserves from Rs 329.91 Cr to Rs 810.53 Cr in the same period.

Blue Jet Healthcare Debt Reduction

Interestingly, Blue Jet Healthcare managed to reduce its borrowings dramatically to zero by March 2022, maintaining this status through to March 2024. This elimination of borrowings reflects a strong balance sheet, reducing the company's financial risk and potentially improving its creditworthiness.

Blue Jet Healthcare Asset Accumulation

Reviewing the assets side, Blue Jet Healthcare's total assets paralleled liabilities with an increase to Rs 1,214.47 Cr by March 2024. A notable change was in Capital WIP, jumping from Rs 2.58 Cr in 2021 to Rs 147.06 Cr in 2024, indicating ongoing expansions or investments in new projects. Despite these changes, Intangible WIP remained at zero across the years surveyed.

This analysis is based on the standalone Balance Sheet of the company.

Through ongoing financial improvements, Blue Jet Healthcare remains a significant entity in sector analyses and could be an interesting point of study for market indices or investor considerations.

Read More
X